[EN] TETRAHYDROPYRAZOLO [1,5 -A] PYRIMIDINE AS ANTI -TUBERCULOSIS COMPOUNDS<br/>[FR] COMPOSÉS ANTITUBERCULEUX À BASE DE TÉTRAHYDRO-PYRAZOLO[1,5 -A]PYRIMIDINE
申请人:GLAXO GROUP LTD
公开号:WO2012143522A1
公开(公告)日:2012-10-26
A compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 represents a group selected from: i) phenyl optionally substituted with one or two substituents independently selected from Me, OMe, CF3, F, CI and NMe2; ii) furanyl, thiophenyl, pyrrolyl, pyridyl, cyclohexyl or naphthyl, each of which is optionally substituted with one or two substituents independently selected from Me, OMe, CF3, F, CI and NMe2; and iii) benzo[1,3]dioxo5-yl or 2,3-dihydrobenzo[1,4]dioxin-6-yl; R2 represents CF3, C1-4alkyl, or CHF2; When R1 represents optionally substituted furanyl, thiophenyl, pyrrolyl, pyridyl or naphthyl, R3 represents Et; When R1 represents optionally substituted cyclohexyl, R3 represents Et or Me; Otherwise R3 represents Et, Me, Br or OMe, compositions containing them, their use in therapy, for example in the treatment of tuberculosis, and methods for the preparation of such compounds, are provided, together with certain novel compounds
化合物的化学式(I)或其药用盐,其中R1代表以下之一的基团:i)苯基,可选择一个或两个取代基,独立选择自Me、OMe、CF3、F、CI和NMe2;ii)呋喃基、噻吩基、吡咯基、吡啶基、环己基或萘基,每个基团可选择一个或两个取代基,独立选择自Me、OMe、CF3、F、CI和NMe2;iii)苯并[1,3]二氧杂环戊烯-5-基或2,3-二氢苯并[1,4]二氧杂环戊烷-6-基;R2代表CF3、C1-4烷基或CHF2;当R1代表可选择的取代基呋喃基、噻吩基、吡咯基、吡啶基或萘基时,R3代表乙基;当R1代表可选择的取代基环己基时,R3代表乙基或甲基;否则R3代表乙基、甲基、溴或OMe,含有它们的组合物,它们在治疗中的用途,例如在结核病治疗中的用途,以及制备这类化合物的方法,以及一些新颖的化合物。